Q4 2024 TCM Group A/S Earnings Call Transcript
Key Points
- B2C sales increased by more than 5% in the fourth quarter, showing strong consumer demand.
- Adjusted EBIT improved significantly to DKK30 million from DKK18 million in Q4 last year, with an EBIT margin increase from 5.8% to 9.9%.
- The company reported a strong cash conversion rate of 84.3%, indicating efficient cash management.
- TCM Group AS (OCSE:TCM) plans to acquire the remaining 55% of Celebert, which has shown impressive revenue and earnings growth.
- The company achieved a gross margin increase from 22.3% to 22.5% due to a favorable sales mix with higher-margin B2C sales.
- Overall sales declined by 2% due to a downturn in B2B project sales.
- Revenue in Norway decreased by 10.7% due to challenging trading conditions.
- Administrative expenses were relatively high in Q4, impacting overall profitability.
- Supply chain bottlenecks, particularly in lacquering capacity, increased production costs and affected margins.
- Visibility for B2B growth in the second half of the year is low, creating uncertainty in future projections.
/- -
Good morning, ladies and gentlemen, and welcome to the presentation of the fourth-quarter results for TCM Group. Presenters today are our CFO Thomas Hjannung and myself, CEO Torben Paulin. We will comment on the business and the financial results, after which we will hand over to the operator for the Q&A session. Let us start the presentation and turn to page 2 for the business update.
Sales in the fourth quarter developed as expected with declining B2B project sales and a solid uplift in B2C sales. Due to the decline in the B2B project sales, our sales declined by only 2% compared to Q4 2023, and we are pleased to report that B2C sales increased by more than 5% in the quarter. Despite the downturn in B2B, our order intake developed positively in the quarter, again, supported by a double-digit growth in B2C orders. The gross margin improved slightly in the quarter as the positive impacts from the improved sales mix was offset by increased production costs
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
